In Vitro and In Vivo Models to Assess the Immune-Related Effects of Nanomaterials
The immunological safety of drugs, nanomaterials and contaminants is a central point in the regulatory evaluation and safety monitoring of working and public places and of the environment. In fact, anomalies in immune responses may cause diseases and hamper the physical and functional integrity of l...
Enregistré dans:
Auteurs principaux: | Diana Boraschi, Dongjie Li, Yang Li, Paola Italiani |
---|---|
Format: | article |
Langue: | EN |
Publié: |
MDPI AG
2021
|
Sujets: | |
Accès en ligne: | https://doaj.org/article/a792537d2fdf44778fe9a6b51f74b259 |
Tags: |
Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!
|
Documents similaires
-
Comparisons of in vitro Fick’s first law, lipolysis, and in vivo rat models for oral absorption on BCS II drugs in SNEDDS
par: Ye J, et autres
Publié: (2019) -
Assessing Intestinal Health. In Vitro and Ex vivo Gut Barrier Models of Farm Animals: Benefits and Limitations
par: Federico Ghiselli, et autres
Publié: (2021) -
In vivo Pooled Screening: A Scalable Tool to Study the Complexity of Aging and Age-Related Disease
par: Martin Borch Jensen, et autres
Publié: (2021) -
Corrigendum: In Vivo Pooled Screening: A Scalable Tool to Study the Complexity of Aging and Age-Related Disease
par: Martin Borch Jensen, et autres
Publié: (2021) -
The Challenging Melanoma Landscape: From Early Drug Discovery to Clinical Approval
par: Mariana Matias, et autres
Publié: (2021)